BioNexus Gene Lab (BGLC) Non Operating Income (2024 - 2026)

BioNexus Gene Lab has disclosed Non Operating Income across 3 years of filings, most recently posting $57686.0 for Q1 2026.

• Non Operating Income for Q1 2026 came in at $57686.0, down 36.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $398383.0 (down 79.7% YoY), and the FY2025 annual result was $432117.0, down 79.15% from the prior year.
• Non Operating Income came in at $57686.0 for Q1 2026 at BioNexus Gene Lab, up from $23476.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $730105.0 in Q2 2024 to a low of $23476.0 in Q4 2025.
• The 3-year median for Non Operating Income is $201847.0 (2024), against an average of $284697.3.
• Across the five-year window, Non Operating Income plunged 96.52% in 2025 and slumped 36.9% in 2026, its largest moves.
• BioNexus Gene Lab's Non Operating Income stood at $674994.0 in 2024, then slumped by 96.52% to $23476.0 in 2025, then soared by 145.72% to $57686.0 in 2026.
• The last three Non Operating Income figures came in at $57686.0 (Q1 2026), $23476.0 (Q4 2025), and $107760.0 (Q3 2025), per Business Quant data.